Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7566552

Protection against environmental toxicity through manipulation of the processing of messen

CropDesign N.V. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566451

Human immunodeficiency virus-neutralizing human antibodies with improved breadth and poten

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7560118

Attenuated dengue virus comprising mutations in the NS3 gene

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7547509

Cyanovirin variant-polymer conjugates

Nektar Therapeutics AL, Corporation · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7537765

Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7534613

Methods of treating parkinson's disease using viral vectors

The Regents of the University of California · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7528274

Acylthiols and component thiol compositions as anti-HIV and anti-retroviral agents

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7524508

Subgenomic replicons of the flavivirus dengue

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7521177

Flavivirus detection methods employing recombinant antigens comprising a Japanese encephal

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7517531

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of den

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7511124

Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral age

The Board of Regents of the University of Texas System · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7507538

Human papilloma virus immunoreactive peptides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7498353

Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Mar 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7494988

Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7491798

Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, c

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7485415

Sequence analysis of the tetravalent rotavirus vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7485440

Production of attenuated respiratory syncytial virus vaccines involving modification of M2

granted patent

US 7482150

Virulent systemic feline calicivirus

The Regents of the University of California · Granted Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7479280

Virus-like particles for the induction of autoantibodies

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7479484

Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral a

Takeda Pharmaceutical Company Limited · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7476382

Reovirus for the treatment of neoplasia

ONCOLYTICS BIOTECH INC. · Granted Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7473780

Drying process for preparing crystalline solid famciclovir

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7473772

Chimeric GB virus B (GBV-B)

The Board of Regents of the University of Texas System · Granted Tue Jan 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7465794

Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modul

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted